Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
SI-BONE, Inc.
Insider Laura Francis of SI-BONE, Inc. reported a change in beneficial ownership of securities effective October 12, 2026. This filing is a Form 4 statement submitted to the SEC regarding executive stock holdings.…more
SI-BONE, Inc.
Francis Laura, an insider at SI-BONE, Inc., has filed an SEC Form 144 to report a proposed sale of company shares. This is a standard disclosure regarding the planned disposition of insider holdings.…more
SI-BONE, Inc.
Insider Michael A. Pisetsky of SI-BONE, Inc. reported changes in beneficial ownership of securities as of October 2, 2026. This filing is a Form 4 statement detailing the insider's updated equity holdings.…more
24 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
SI-BONE to Report Third Quarter 2026 Financial Results on November 2
Medical device company SI-BONE announced it will release its financial results for the third quarter of 2026 after the market closes on November 2. Management will host a conference call to discuss the results following the announcement.…more
●●●●●●●● ●●●●● ●●●●●●
SI-BONE has received FDA 510(k) clearance for its iFuse Granite Onyx System, a product designed to address hardware loosening in spinal fusion procedures. This approval allows the company to expand its 3D-printed bone integration platform beyond the pelvis.…more
●●●●●●●● ●●●●● ●●●●●●
SI-BONE announced its participation in the upcoming Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026. This event is a standard investor relations activity and does not provide new material financial information.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.